132 related articles for article (PubMed ID: 14638359)
1. Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma.
Hiasa Y; Kamegaya Y; Nuriya H; Onji M; Kohara M; Schmidt EV; Chung RT
Am J Gastroenterol; 2003 Nov; 98(11):2528-34. PubMed ID: 14638359
[TBL] [Abstract][Full Text] [Related]
2. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.
Chen GG; Lai PB; Ho RL; Chan PK; Xu H; Wong J; Lau WY
J Med Virol; 2004 Jun; 73(2):187-94. PubMed ID: 15122791
[TBL] [Abstract][Full Text] [Related]
3. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH
Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the E2-PePHD region of hepatitis C virus type 1b in patients with hepatocellular carcinoma.
Bagaglio S; De Mitri MS; Lodrini S; Paties C; Cassini R; Bianchi G; Bernardi M; Lazzarin A; Morsica G
J Viral Hepat; 2005 May; 12(3):243-50. PubMed ID: 15850464
[TBL] [Abstract][Full Text] [Related]
5. Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein.
Delhem N; Sabile A; Gajardo R; Podevin P; Abadie A; Blaton MA; Kremsdorf D; Beretta L; Brechot C
Oncogene; 2001 Sep; 20(41):5836-45. PubMed ID: 11593389
[TBL] [Abstract][Full Text] [Related]
6. Variation of hepatitis C virus load, hypervariable region 1 quasispecies and CD81 hepatocyte expression in hepatocellular carcinoma and adjacent non-cancerous liver.
Young KC; Lin PW; Hsiao WC; Chang TT; Chang YC; Wu HL
J Med Virol; 2002 Oct; 68(2):188-96. PubMed ID: 12210407
[TBL] [Abstract][Full Text] [Related]
7. Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.
Lee HH; Uen YH; Tian YF; Sun CS; Sheu MJ; Kuo HT; Koay LB; Lin CY; Tzeng CC; Cheng CJ; Tang LY; Tsai SL; Wang AH
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1562-9. PubMed ID: 19423534
[TBL] [Abstract][Full Text] [Related]
8. The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma.
Iavarone M; Lampertico P; Seletti C; Francesca Donato M; Ronchi G; del Ninno E; Colombo M
Cancer; 2003 Aug; 98(3):529-34. PubMed ID: 12879470
[TBL] [Abstract][Full Text] [Related]
9. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract][Full Text] [Related]
10. Thr 446 phosphorylation of PKR by HCV core protein deregulates G2/M phase in HCC cells.
Alisi A; Mele R; Spaziani A; Tavolaro S; Palescandolo E; Balsano C
J Cell Physiol; 2005 Oct; 205(1):25-31. PubMed ID: 15880455
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the inhibitory effect of antisense oligodeoxynucleotides on the growth of hepatitis C-associated hepatocellular carcinoma cells in vitro.
Amin MA; Awadein MR; Gabr H
Chin J Dig Dis; 2005; 6(3):142-8. PubMed ID: 16045605
[TBL] [Abstract][Full Text] [Related]
12. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
13. PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control.
Kang JI; Kwon SN; Park SH; Kim YK; Choi SY; Kim JP; Ahn BY
Virus Res; 2009 Jun; 142(1-2):51-6. PubMed ID: 19189853
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
[TBL] [Abstract][Full Text] [Related]
15. Translational insensitivity to potent activation of PKR by HCV IRES RNA.
Shimoike T; McKenna SA; Lindhout DA; Puglisi JD
Antiviral Res; 2009 Sep; 83(3):228-37. PubMed ID: 19467267
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
[TBL] [Abstract][Full Text] [Related]
17. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
18. Implication of protein kinase R gene quantification in hepatitis C virus genotype 4 induced hepatocarcinogenesis.
Mohamed AA; Nada OH; El Desouky MA
Diagn Pathol; 2012 Aug; 7():103. PubMed ID: 22894766
[TBL] [Abstract][Full Text] [Related]
19. Detection of hepatitis C virus RNA sequences in hepatocellular carcinoma and its precursors by microdissection polymerase chain reaction.
Saito K; Sullivan D; Haruna Y; Theise ND; Thung SN; Gerber MA
Arch Pathol Lab Med; 1997 Apr; 121(4):400-3. PubMed ID: 9140311
[TBL] [Abstract][Full Text] [Related]
20. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]